0001439222-23-000105.txt : 20230630 0001439222-23-000105.hdr.sgml : 20230630 20230630160633 ACCESSION NUMBER: 0001439222-23-000105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230628 FILED AS OF DATE: 20230630 DATE AS OF CHANGE: 20230630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gheuens Sarah CENTRAL INDEX KEY: 0001881190 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 231061740 MAIL ADDRESS: STREET 1: C/O AGIOS PHARMACEUTICALS, INC. STREET 2: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-8600 MAIL ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20080703 4 1 wk-form4_1688155583.xml FORM 4 X0407 4 2023-06-28 1 0001439222 AGIOS PHARMACEUTICALS, INC. AGIO 0001881190 Gheuens Sarah 88 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Medical Officer 1 Common stock 2023-06-28 4 M 0 5750 0 A 25866 D Common stock 2023-06-30 4 S 0 1707 28.36 D 24159 D Performance share units 2023-06-28 4 M 0 5750 0 D Common stock 5750 5750 D Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. Each performance share unit represents a contingent right to receive one share of the issuer's common stock. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified clinical milestone and as to 50% of the underlying shares upon the achievement of a specified research milestone. The performance criteria for the specified clinical milestone was determined to have been met on June 28, 2023, resulting in the vesting of the PSUs as to 50% of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. /s/ William Cook, as attorney-in-fact for Sarah Gheuens 2023-06-30